Tandem Diabetes Care to Present at the BofA Securities 2023 Health Care Conference

Rhea-AI Summary

Tandem Diabetes Care (NASDAQ: TNDM) announced a company update presentation scheduled for May 10, 2023, at 4:40 PM Eastern Time during the BofA Securities 2023 Health Care Conference. The live event will be accessible via webcast, with an archive available for 30 days afterward.

The presentation will highlight Tandem's commitment to innovation in insulin delivery and diabetes technology, emphasizing their human-centered design approach. The company manufactures the t:slim X2 insulin pump featuring Control-IQ technology, aimed at enhancing the management of diabetes for users and healthcare providers.

For more details, the webcast link can be found on Tandem’s Investor Center website under the “Events & Presentations” section.

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the BofA Securities 2023 Health Care Conference on Wednesday, May 10, 2023 at 4:40pm Eastern Time (1:40pm Pacific Time).

The Company update presentation will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience. The Company’s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. For more information, visit tandemdiabetes.com.

Tandem Diabetes Care and Control-IQ are trademarks registered in the U.S. and/or other countries and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2 and #TandemDiabetes.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230420005072/en/

Media Contact:

858-255-6388

media@tandemdiabetes.com

Investor Contact:

858-366-6900

IR@tandemdiabetes.com

Source: Tandem Diabetes Care, Inc.

FAQ

What date will Tandem Diabetes Care present at the BofA Securities Health Care Conference?

Tandem Diabetes Care will present on May 10, 2023.

What time will Tandem's presentation take place?

The presentation is scheduled for 4:40 PM Eastern Time.

Where can I watch the Tandem Diabetes Care presentation?

The presentation will be available via live webcast on Tandem's Investor Center website.

What is the main focus of Tandem Diabetes Care's presentation?

The presentation will provide a company update, focusing on their innovations in insulin delivery and diabetes technology.

How long will the archived presentation be available?

The archived presentation will be available for 30 days after the live event.

What product does Tandem Diabetes Care manufacture?

Tandem Diabetes Care manufactures the t:slim X2 insulin pump with Control-IQ technology.